Raghad F. Almilly

Diabetic Foot Ulcers Healing Promoted by Novel Glibenclamide-loaded Micelle Wound Dressing

Maryam Al-Ghezi, Raghad F. Almilly & Wedad K. Ali · Journal of Pharmaceutical Research International · 2022

Diabetic foot ulcers (DFU) are chronic wounds, which do not respond to traditional wound treatments. In this work, wound dressings of glibenclamide (GB) incorporated into a  novel mixed matrix were fabricated in the aim of accelerating the healing process of diabetic wounds. GB w...

Open access Research Article 10.9734/jpri/2022/v34i53B7230

Glibenclamide-Loaded Polyvinylpyrrolidone (PVP) Nanoparticles and Glibenclamide-Loaded Soluplus® Nanomicelles Intended for Parenteral Administration: Effect of Solvents Mixtures on the Electrosprayed Nanoparticles and In vitro Characterization

Maryam Al-Ghezi, Raghad F. Almilly & Wedad K. Ali · Journal of Pharmaceutical Research International · 2021

Background and Objective: Glibenclamide (GB) is showing promising results in central nervous system (CNS) injuries treatment where intravenous administration of GB could overcome the oral limitations and assure maximum bioavailability. Dry powder of GB nanoparticles reconstituted...

Open access Research Article 10.9734/jpri/2021/v33i53A33657